These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 1445978

  • 1. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987.
    Nielsen SV, Henrichsen J.
    Clin Infect Dis; 1992 Nov; 15(5):794-8. PubMed ID: 1445978
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
    Giebink GS, Meier JD, Quartey MK, Liebeler CL, Le CT.
    J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
    [Abstract] [Full Text] [Related]

  • 3. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J.
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [Abstract] [Full Text] [Related]

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 5. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY, Choi EH, Kang JH, Kim KH, Kim DS, Kim YJ, Ahn YM, Eun BW, Oh SH, Cha SH, Cho HK, Hong YJ, Kim KN, Kim NH, Kim YK, Kim JH, Lee H, Lee T, Kim HM, Lee KS, Kim CS, Park SE, Kim YM, Oh CE, Ma SH, Jo DS, Choi YY, Lee J, Bae GR, Park O, Park YJ, Kim ES, Lee HJ.
    J Korean Med Sci; 2016 Jul 31; 31(7):1082-8. PubMed ID: 27366006
    [Abstract] [Full Text] [Related]

  • 6. Seroepidemiology of invasive pneumococcal disease in Queensland, 1990 to 1997.
    Gratten M, Carlisle J, Hanna J, Bapty G, George N, Nuttall N, Nimmo G, Schooneveldt J, Kelly R, Alfredson D.
    Commun Dis Intell; 1998 Nov 26; 22(12):265-9. PubMed ID: 9882923
    [Abstract] [Full Text] [Related]

  • 7. The future of pneumococcal disease prevention.
    Rodgers GL, Klugman KP.
    Vaccine; 2011 Sep 14; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [Abstract] [Full Text] [Related]

  • 8. Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia.
    Gratten M, Torzillo P, Morey F, Dixon J, Erlich J, Hagger J, Henrichsen J.
    J Clin Microbiol; 1996 Feb 14; 34(2):338-41. PubMed ID: 8789011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden.
    Hedlund J, Sörberg M, Henriques Normark B, Kronvall G.
    Scand J Infect Dis; 2003 Feb 14; 35(8):452-8. PubMed ID: 14514143
    [Abstract] [Full Text] [Related]

  • 12. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar 14; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 13. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F, Smaoui H, Kechrid A.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [Abstract] [Full Text] [Related]

  • 14. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, Eskola J.
    Pediatr Infect Dis J; 2004 Feb 31; 23(2):91-8. PubMed ID: 14872172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.
    Park C, Kwon EY, Choi SM, Cho SY, Byun JH, Park JY, Lee DG, Kang JH, Shin J, Kim H.
    Hum Vaccin Immunother; 2017 May 04; 13(5):1169-1176. PubMed ID: 27960627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies.
    Sniadack DH, Schwartz B, Lipman H, Bogaerts J, Butler JC, Dagan R, Echaniz-Aviles G, Lloyd-Evans N, Fenoll A, Girgis NI.
    Pediatr Infect Dis J; 1995 Jun 04; 14(6):503-10. PubMed ID: 7667055
    [Abstract] [Full Text] [Related]

  • 19. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 Dec 10; 59(RR-11):1-18. PubMed ID: 21150868
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.